Vice President, Market Access Consulting

TL;DR

Vice President, Market Access Consulting (Healthcare): Drive growth and development of consultative services for life sciences clients with an accent on market access, reimbursement, and payer-provider-patient solutions. Focus on achieving revenue goals, building client relationships, leading consulting teams, and navigating Medicare payment dynamics and drug commercialization lifecycles.

Location: New York, NY, USA

Salary: $196,000 - $275,000 USD

Company

Award-winning global healthcare market access consultancy helping biopharma clients with pricing, reimbursement, contracting, and commercialization strategies.

What you will do

• Deliver market access engagements across payer, provider, and patient solutions
• Achieve revenue and sales goals through direct client engagement and project support
• Provide leadership to the consulting team on high-quality services for biopharma clients
• Support hiring, staffing, people development, and culture building
• Collaborate across business units on strategy and execution
• Build new business opportunities and maintain long-term client partnerships

Requirements

• Bachelor’s degree in science, economics, business or related; master’s or PhD preferred
• 10+ years in consulting or commercialization strategy, focused on health policy and physician-administered medicine reimbursement
• Proven track record in revenue generation and business development
• Strong understanding of CMS regulations, coding, payment methodologies, and physician reimbursement
• Excellent communication, leadership, team development, client relationship, process development, and strategic consultation skills

Culture & Benefits

• Competitive compensation with discretionary annual bonus
• Health insurance, retirement savings, life insurance, disability benefits, parental leave, paid time off
• Balanced work environment fostering professional growth and work-life harmony
• Apprenticeship model for team development
• Work on cutting-edge therapeutics like rare disease, cell/gene therapy, oncology, and vaccines